311 related articles for article (PubMed ID: 32825798)
41. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
43. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.
Qiao X; Liu J; Zhu L; Song R; Zhong M; Guo Y
Int J Med Sci; 2021; 18(16):3728-3737. PubMed ID: 34790046
[TBL] [Abstract][Full Text] [Related]
45. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.
Huang Z; Zhang Y; Li H; Zhou Y; Zhang Q; Chen R; Jin T; Hu K; Li S; Wang Y; Chen W; Huang Z
Cell Death Dis; 2019 Dec; 10(12):936. PubMed ID: 31819048
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
48. Propofol induces apoptosis and ameliorates 5‑fluorouracil resistance in OSCC cells by reducing the expression and secretion of amphiregulin.
Yang KS; Che PC; Hsieh MJ; Lee IN; Wu YP; Chen MS; Chen JC
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34859260
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-kappaB-suppressed pathway.
Azuma M; Tamatani T; Ashida Y; Takashima R; Harada K; Sato M
Oral Oncol; 2003 Apr; 39(3):282-9. PubMed ID: 12618201
[TBL] [Abstract][Full Text] [Related]
50. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
51. Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma.
Nakatani K; Wada T; Nakamura M; Uzawa K; Tanzawa H; Fujita S
J Cancer Res Clin Oncol; 2005 Jul; 131(7):445-52. PubMed ID: 15856296
[TBL] [Abstract][Full Text] [Related]
52. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
[TBL] [Abstract][Full Text] [Related]
54. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
Lu X; Wang Z; Huang H; Wang H
J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
[TBL] [Abstract][Full Text] [Related]
55. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.
Aminuddin A; Ng PY; Leong CO; Chua EW
Sci Rep; 2020 May; 10(1):7885. PubMed ID: 32398775
[TBL] [Abstract][Full Text] [Related]
57. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Alcalde RE; Matsumura T
Cancer Chemother Pharmacol; 2000; 46(3):241-5. PubMed ID: 11021742
[TBL] [Abstract][Full Text] [Related]
58. Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells.
Ansari SS; Sharma AK; Soni H; Ali DM; Tews B; König R; Eibl H; Berger MR
Cell Death Dis; 2018 Feb; 9(3):296. PubMed ID: 29463797
[TBL] [Abstract][Full Text] [Related]
59. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
[TBL] [Abstract][Full Text] [Related]
60. Interferon γ suppresses dentin sialophosphoprotein in oral squamous cell carcinoma cells resulting in antitumor effects, via modulation of the endoplasmic reticulum response.
Gkouveris I; Nikitakis NG; Aseervatham J; Ogbureke KUE
Int J Oncol; 2018 Dec; 53(6):2423-2432. PubMed ID: 30320380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]